Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene

被引：15

作者：

Divyakant, B. Patel ^{[1
]}

Valay, R. Modi ^{[1
]}

Alok, N. Thakkar ^{[1
]}

Arpita, A. Patel ^{[1
]}

Hetal, P. Thakkar ^{[1
]}

机构：

[1] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara, Gujarat, India

来源：

JOURNAL OF PHARMACY AND BIOALLIED SCIENCES | 2012年 / 4卷 / 05期

关键词：

Drug entrapment; estrogen; solvent emulsification; zeta potential;

D O I：

10.4103/0975-7406.94121

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The objective of this study was to increase the oral bioavailability of Raloxifene having an absolute bioavailability only 2% due to extensive first pass hepatic metabolism by incorporating it in Solid Lipid Nanoparticles (SLNs). The optimized RSLNs prepared by Ultrasonic Emulsification and Low Temperature Solidification method showed the mean particle size, zeta potential and percentage drug entrapment of 101.4 +/- 3.5 nm, 19.4 +/- 0.279 mv, 97.67 +/- 1.02% respectively. The in-vitro intestinal permeability study indicated significantly higher permeation of the RSLNs than the marketed preparation. The in-vivo studies showed that pharmacokinetic parameters for the RSLNs were 3.5 times higher than the marketed preparation indicating significant increase in the oral bioavailability of the Raloxifene.

引用

页码：S14 / S16

页数：3

共 50 条

[31] Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability
Du, Xinhui
Gao, Na
Song, Xiaoyong
[J]. DRUG DELIVERY, 2021, 28 (01) : 252 - 260
[32] SOLID LIPID NANOPARTICLES FOR ENHANCEMENT OF ORAL BIOAVILABILITY OF CEFPODOXIME PROXETIL
Nimbalkar, U. A.
Dhoka, M. V.
Sonawane, P. A.
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (11): : 2974 - 2982
[33] Lipid nanoparticles for enhancing oral bioavailability
Gangavarapu, Anushareddy
Tapia-Lopez, Lillian V.
Sarkar, Barnali
Pena-Zacarias, Jaqueline
Badruddoza, Abu Zayed Md
Nurunnabi, Md
[J]. NANOSCALE, 2024,
[34] Development and evaluation of Eudragit coated environmental sensitive solid lipid nanoparticles using central composite design module for enhancement of oral bioavailability of linagliptin
Veni, D. Krishna
Gupta, N. Vishal
[J]. INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2020, 69 (07) : 407 - 418
[35] Biomimetic Solid Lipid Nanoparticles for Oral Bioavailability Enhancement of Low Molecular Weight Heparin and Its Lipid Conjugates: In Vitro and in Vivo Evaluation
Paliwal, Rishi
Paliwal, Shivani R.
Agrawal, Govind P.
Vyas, Suresh P.
[J]. MOLECULAR PHARMACEUTICS, 2011, 8 (04) : 1314 - 1321
[36] Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of Paclitaxel
Pandita, Deepti
Ahuja, Alka
Lather, Viney
Benjamin, Biju
Dutta, Tathagata
Velpandian, Thirumurthy
Khar, Roop Krishen
[J]. AAPS PHARMSCITECH, 2011, 12 (02): : 712 - 722
[37] Improved Oral Bioavailability and Liver Targeting of Sorafenib Solid Lipid Nanoparticles in Rats
Wang, Haipeng
Wang, Huiyun
Yang, Wenlong
Yu, Mengjie
Sun, Shuilin
Xie, Baogang
[J]. AAPS PHARMSCITECH, 2018, 19 (02): : 761 - 768
[38] Improved uptake and bioavailability of cinnamaldehyde via solid lipid nanoparticles for oral delivery
Wu, Long
Meng, Yun
Xu, Yuhang
Chu, Xiaoqin
[J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2022, 27 (10) : 1038 - 1048
[39] Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of Paclitaxel
Deepti Pandita
Alka Ahuja
Viney Lather
Biju Benjamin
Tathagata Dutta
Thirumurthy Velpandian
Roop Krishen Khar
[J]. AAPS PharmSciTech, 2011, 12 : 712 - 722
[40] Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles
Hu, LianDong
Xing, Qianbin
Meng, Jian
Shang, Chuang
[J]. AAPS PHARMSCITECH, 2010, 11 (02): : 582 - 587

← 1 2 3 4 5 →